Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.2 USD | -0.34% | -0.85% | +81.42% |
Financials (USD)
Sales 2024 * | 197M | Sales 2025 * | 218M | Capitalization | 878M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -52M | EV / Sales 2024 * | 4.39 x |
Net cash position 2024 * | 11.13M | Net cash position 2025 * | 41.33M | EV / Sales 2025 * | 3.83 x |
P/E ratio 2024 * |
-16.3
x | P/E ratio 2025 * |
-17
x | Employees | 474 |
Yield 2024 * |
0.57% | Yield 2025 * |
-
| Free-Float | 95.74% |
Latest transcript on Silk Road Medical, Inc
1 day | -0.31% | ||
1 week | -0.85% | ||
Current month | +14.51% | ||
1 month | +25.98% | ||
3 months | +30.94% | ||
6 months | +172.79% | ||
Current year | +81.42% |
Managers | Title | Age | Since |
---|---|---|---|
Charles McKhann
CEO | Chief Executive Officer | 55 | Nov. 01 |
Lucas Buchanan
DFI | Director of Finance/CFO | 46 | 09-07-31 |
William Whealon
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 18-03-25 |
Kevin Ballinger
BRD | Director/Board Member | 51 | 20-12-02 |
Jack Lasersohn
CHM | Chairman | 70 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 22.23 | -0.18% | 208 905 |
24-05-22 | 22.27 | +1.04% | 563,941 |
24-05-21 | 22.04 | -3.08% | 556,737 |
24-05-20 | 22.74 | +2.52% | 376,140 |
24-05-17 | 22.18 | -1.20% | 491,374 |
Delayed Quote Nasdaq, May 23, 2024 at 01:05 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.42% | 878M | |
-5.08% | 182B | |
+0.15% | 114B | |
-5.40% | 67.76B | |
+3.05% | 51.91B | |
+7.09% | 43.23B | |
+6.07% | 41.07B | |
+23.28% | 32.07B | |
+15.86% | 25B | |
-3.10% | 24.55B |
- Stock Market
- Equities
- SILK Stock